Black Diamond Therapeutics (BDTX) News Today → I’m officially sounding the alarm. (From Altimetry) (Ad) Free BDTX Stock Alerts $5.21 -0.09 (-1.70%) (As of 09:39 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCognition Therapeutics (NASDAQ:CGTX) and Black Diamond Therapeutics (NASDAQ:BDTX) Head to Head Reviewamericanbankingnews.com - April 17 at 4:10 AMShort Interest in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Expands By 12.7%marketbeat.com - April 14 at 4:21 PMBlack Diamond Therapeutics, Inc. Expected to Earn Q1 2024 Earnings of ($0.41) Per Share (NASDAQ:BDTX)americanbankingnews.com - April 12 at 1:20 AMBlack Diamond Therapeutics Announces Changes to Board of Directorsglobenewswire.com - April 11 at 8:00 AMBrokers Set Expectations for Black Diamond Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:BDTX)marketbeat.com - April 11 at 7:10 AMWedbush Increases Black Diamond Therapeutics (NASDAQ:BDTX) Price Target to $16.00americanbankingnews.com - April 9 at 3:12 AMWall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should Knowfinance.yahoo.com - April 8 at 3:09 PMBlack Diamond Therapeutics (NASDAQ:BDTX) Price Target Raised to $16.00 at Wedbushmarketbeat.com - April 8 at 11:37 AMBlack Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meetingglobenewswire.com - April 7 at 6:00 PMBlack Diamond Therapeutics to Participate in Upcoming Investor Conferencesglobenewswire.com - April 3 at 8:00 AMEquities Analysts Issue Forecasts for Black Diamond Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:BDTX)marketbeat.com - March 20 at 5:46 AMBlack Diamond Therapeutics (NASDAQ:BDTX) Earns Buy Rating from HC Wainwrightmarketbeat.com - March 18 at 5:32 PMBlack Diamond Therapeutics, Inc. Forecasted to Earn FY2024 Earnings of ($1.76) Per Share (NASDAQ:BDTX)marketbeat.com - March 18 at 2:04 AMBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Decline in Short Interestmarketbeat.com - March 18 at 1:54 AMBlack Diamond Therapeutics Inc (BDTX) Reports Q4 and Full Year 2023 Financials, Advances ...finance.yahoo.com - March 14 at 9:00 AMBlack Diamond Therapeutics (NASDAQ:BDTX) Stock Rating Reaffirmed by Wedbushmarketbeat.com - March 13 at 10:27 AMBlack Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - March 12 at 8:00 AMBlack Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024globenewswire.com - March 5 at 4:30 PMBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Drop in Short Interestmarketbeat.com - March 2 at 2:31 AMBDTX Black Diamond Therapeutics, Inc.seekingalpha.com - February 29 at 6:00 PMBlack Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conferenceglobenewswire.com - February 28 at 8:00 AMBarclays PLC Acquires 197,895 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)marketbeat.com - February 21 at 4:13 AMBlack Diamond Therapeutics Inc (BDTX)uk.investing.com - February 16 at 8:39 PMBlack Diamond Therapeutics (NASDAQ:BDTX) Trading Up 2.6%marketbeat.com - February 13 at 2:35 AMBlack Diamond Therapeutics Inc.wsj.com - January 24 at 2:19 AMBlack Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestonesfinance.yahoo.com - January 4 at 8:42 AMShort Interest in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Increases By 6.4%marketbeat.com - January 3 at 7:00 AMBlack Diamond reports positive topline data for GBM drugmsn.com - December 14 at 5:23 PMBuy Rating Reaffirmed for Black Diamond Therapeutics Amid Promising BDTX-1535 Trial Results and Strategic Developmentmarkets.businessinsider.com - December 14 at 12:22 PMBlack Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBMfinance.yahoo.com - December 13 at 7:21 AMWith 58% ownership, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) boasts of strong institutional backingfinance.yahoo.com - December 5 at 9:22 AMSolitario: Q3 Earnings Snapshotwashingtonpost.com - November 9 at 7:31 AMBlack Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 6 at 8:16 AMBlack Diamond Therapeutics Inc (BDTX) Reports Q3 2023 Financial Results and Corporate Updatefinance.yahoo.com - November 6 at 8:16 AMBlack Diamond Therapeutics Inc Ordinary Shares BDTXmorningstar.com - October 31 at 2:14 PMAnalysts’ Top Healthcare Picks: Black Diamond Therapeutics (BDTX), Ultragenyx Pharmaceutical (RARE)markets.businessinsider.com - October 17 at 10:28 AMBlack Diamond Therapeutics (BDTX) Receives a Buy from Piper Sandlermarkets.businessinsider.com - October 16 at 8:22 AMBlack Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535finance.yahoo.com - October 14 at 1:35 PMBlack Diamond's BDTX-1535: A Brainy Bet In Cancer Therapymsn.com - October 12 at 9:45 AMBlack Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeuticsfinance.yahoo.com - October 4 at 2:07 PMCo-founder of cancer biotech Black Diamond replaced as CEOfinance.yahoo.com - September 18 at 1:35 PMBlack Diamond Therapeutics Chairman to Succeed Departing CEOmarketwatch.com - September 18 at 7:46 AMBlack Diamond Therapeutics Announces CEO Transitionfinance.yahoo.com - September 18 at 7:46 AMWedbush Reiterates Black Diamond Therapeutics (BDTX) Outperform Recommendationmsn.com - September 12 at 4:26 PMPiper Sandler Keeps Their Buy Rating on Black Diamond Therapeutics (BDTX)markets.businessinsider.com - August 14 at 10:38 AMBlack Diamond Therapeutics, Inc: Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - August 11 at 6:18 PMBlack Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 11 at 6:18 PMBDTX - Black Diamond Therapeutics, Inc.finance.yahoo.com - August 1 at 3:30 PMShort Interest in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Declines By 38.4%marketbeat.com - July 28 at 8:58 AMBlack Diamond Therapeutics (NASDAQ:BDTX) Receives New Coverage from Analysts at Piper Sandlermarketbeat.com - July 14 at 8:21 AM Get Black Diamond Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address I’m officially sounding the alarm. (Ad)AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone. Just click here to watch my full uncensored interview. BDTX Media Mentions By Week BDTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BDTX News Sentiment▼1.430.53▲Average Medical News Sentiment BDTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BDTX Articles This Week▼31▲BDTX Articles Average Week Get Black Diamond Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: STRO News Today CHRS News Today PSTX News Today IPSC News Today FENC News Today CRDF News Today ADVM News Today OPT News Today KOD News Today ABOS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BDTX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceUrgent alert: open this for a huge profit potentialTimothy SykesHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.